News

Professor and Chair Satya dandekar of the Medical Microbiology and Immunology Department, revealed her team's findings of the effect that low levels of cytomegalovirus have on microbe and immune cell populations and their response to the influenza vaccine. 

The University of California, Davis, enabled the foundation of 16 commercial companies during the fiscal year ending June 30, an all-time high for the university. This brings the total number of startups made possible by UC Davis technologies during the past 10 years to 137. Among those startups, Evolve BioSystems, which builds on university research on infant gut microbiome and breast milk components, recently completed a $40 million Series C financing, co-led by Horizons Ventures and the Bill and Melinda Gates Foundation, to expand sales of its flagship infant probiotic product worldwide.  

The University of California, Davis (UC Davis), and BASF announced a collaboration to unlock new benefits of human milk oligosaccharides (HMOs). The long-term objective of this strategic research partnership is to develop and validate second-generation HMO molecules as potent bioactive compounds that can influence the establishment and maintenance of the gut microbiome and provide benefits beyond the gastrointestinal tract, such as brain health, for infants, children and adults.

Professor Bruce German from the Department of Food Science & Technology at UC Davis talks about the link between bacteria and human breast milk in ABC's (Australia Broadcasting Corporation) "Babytalk" podcast by Penny Johnston (39min).